Close

Mizuho Securities Upgrades Biogen (BIIB) to Buy

October 17, 2017 6:58 AM EDT Send to a Friend
Mizuho Securities upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $400.00 (from $319.00).Analyst Salim Syed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login